These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Anaplastic lymphoma kinase (ALK) positive diffuse large B cell lymphoma in a 20 year old: a rare entity. Sachdev R; Goel S; Gupta S; Sood N Indian J Pathol Microbiol; 2014; 57(1):157-8. PubMed ID: 24739865 [No Abstract] [Full Text] [Related]
24. Diffuse large B-cell lymphoma with MYC gene rearrangements: Current perspective on treatment of diffuse large B-cell lymphoma with MYC gene rearrangements; case series and review of the literature. de Jonge AV; Roosma TJ; Houtenbos I; Vasmel WL; van de Hem K; de Boer JP; van Maanen T; Lindauer-van der Werf G; Beeker A; Timmers GJ; Schaar CG; Soesan M; Poddighe PJ; de Jong D; Chamuleau ME Eur J Cancer; 2016 Mar; 55():140-6. PubMed ID: 26820684 [TBL] [Abstract][Full Text] [Related]
26. Pediatric ALK+ anaplastic large cell lymphoma with t(3;8)(q26.2;q24) translocation and c-myc rearrangement terminating in a leukemic phase. Monaco S; Tsao L; Murty VV; Nandula SV; Donovan V; Oesterheld J; Bhagat G; Alobeid B Am J Hematol; 2007 Jan; 82(1):59-64. PubMed ID: 16955462 [TBL] [Abstract][Full Text] [Related]
27. A small cell variant of ALK-positive, CD8-positive anaplastic large cell lymphoma with primary subcutaneous presentation mimicking subcutaneous panniculitis-like T-cell lymphoma. Wang E; Papalas J; Siddiqi I; Stoecker M; Rehder C; Sebastain S; Burchette J; Huang Q Pathol Res Pract; 2011 Aug; 207(8):522-6. PubMed ID: 21763080 [TBL] [Abstract][Full Text] [Related]
28. ALK+ large B-cell lymphoma: a rare variant of aggressive large B-cell lymphoma mimicking carcinoma on cytology specimens. Lin O; Koreishi A; Brandt SM; Arcila M; Teruya-Feldstein J Diagn Cytopathol; 2013 May; 41(5):404-7. PubMed ID: 22351377 [TBL] [Abstract][Full Text] [Related]
29. Nodal ALK positive anaplastic large cell lymphoma of the axilla with spontaneous regression. Patel P; Godwin J; Velankar M; Alkan S Leuk Lymphoma; 2007 Jun; 48(6):1250-2. PubMed ID: 17577798 [No Abstract] [Full Text] [Related]
30. The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma. Hyo R; Tomita N; Takeuchi K; Aoshima T; Fujita A; Kuwabara H; Hashimoto C; Takemura S; Taguchi J; Sakai R; Fujita H; Fujisawa S; Ogawa K; Motomura S; Suzuki R; Ishigatsubo Y Hematol Oncol; 2010 Mar; 28(1):27-32. PubMed ID: 19358143 [TBL] [Abstract][Full Text] [Related]
31. Nodular lymphocyte predominant Hodgkin lymphoma and diffuse large B-cell lymphoma: a study of six cases concurrently involving the same site. Cotta CV; Coleman JF; Li S; Hsi ED Histopathology; 2011 Dec; 59(6):1194-203. PubMed ID: 22175899 [TBL] [Abstract][Full Text] [Related]
32. Non-Hodgkin's lymphoma: the old and the new. Cabanillas F Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S87-90. PubMed ID: 22035756 [TBL] [Abstract][Full Text] [Related]
33. Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature. Grewal JS; Smith LB; Winegarden JD; Krauss JC; Tworek JA; Schnitzer B Ann Hematol; 2007 Jul; 86(7):499-508. PubMed ID: 17396261 [TBL] [Abstract][Full Text] [Related]
34. Anaplastic large cell lymphoma: a single institution experience from India. Lakshmaiah KC; Guruprasad B; Shah A; Kavitha S; Abraham LJ; Govindbabu K; Aruna Kumari BS; Appaji L J Cancer Res Ther; 2013; 9(4):649-52. PubMed ID: 24518711 [TBL] [Abstract][Full Text] [Related]
35. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. Pittaluga S; Wlodarska I; Pulford K; Campo E; Morris SW; Van den Berghe H; De Wolf-Peeters C Am J Pathol; 1997 Aug; 151(2):343-51. PubMed ID: 9250148 [TBL] [Abstract][Full Text] [Related]
36. Inhibitors of the anaplastic lymphoma kinase. Mologni L Expert Opin Investig Drugs; 2012 Jul; 21(7):985-94. PubMed ID: 22612599 [TBL] [Abstract][Full Text] [Related]
37. Anaplastic lymphoma kinase-positive large B-cell lymphoma: a potential diagnostic pitfall. Yu H; Huang J; Sun J; Wang C; Lin M; Li H Indian J Pathol Microbiol; 2015; 58(2):241-5. PubMed ID: 25885146 [TBL] [Abstract][Full Text] [Related]
38. ALK-negative anaplastic lymphoma after autologous stem cell transplant for relapsed diffuse large B-cell lymphoma. Lim SH; Guileyardo JM; Graham R; Strong LR; Esler WV Leuk Res; 2011 Jun; 35(6):e59-60. PubMed ID: 21146873 [No Abstract] [Full Text] [Related]
39. Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program. Ok CY; Xu-Monette ZY; Tzankov A; O'Malley DP; Montes-Moreno S; Visco C; Møller MB; Dybkaer K; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Han van Krieken J; Ponzoni M; Farnen JP; Piris MA; Winter JN; Medeiros LJ; Young KH Cancer; 2014 Jun; 120(12):1818-29. PubMed ID: 24648050 [TBL] [Abstract][Full Text] [Related]
40. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease. Eyre TA; Khan D; Hall GW; Collins GP Eur J Haematol; 2014 Dec; 93(6):455-68. PubMed ID: 24766435 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]